Geoffrey von Maltzahn
Person ● Covered in 0 stories + Follow ✴ AI Graph Request update
Geoffrey von Maltzahn is co-founder and CEO of Lila Sciences. According to Lila Sciences, he is leading the company’s mission to build scientific superintelligence across life, chemical, and materials sciences. Before Lila Sciences, he served as founding CEO of Generate:Biomedicines, Tessera Therapeutics, Quotient Therapeutics, and Indigo Ag, and he also co-founded Sana Biotechnology and Seres Therapeutics. He is known for founding and co-founding companies that combine biology and AI, and Lila Sciences says he is named inventor on more than 200 patents and patent applications.
Updated 13 September 2026
Public sources: lila.ai
Why this page exists, and how to correct or remove it
This profile is assembled automatically because Geoffrey von Maltzahn appears in coverage we index or holds a role listed publicly by their organisation. It uses only public sources — company and organisation pages, news articles, Wikipedia, and public professional listings — and the biography, if any, is written by AI from those sources and cited above.
We hold it to report on the AI industry, under the legitimate interest of journalistic reporting. You can ask us to correct it, restrict it, or take it down, and you can object at any time — no account needed, no reason required.
Claim or correct this profile Request removal How we handle personal data